» Articles » PMID: 35399229

LINC00152 Knockdown Suppresses Tumorigenesis in Non-small Cell Lung Cancer Via Sponging MiR-16-5p

Overview
Journal J Thorac Dis
Specialty Pulmonary Medicine
Date 2022 Apr 11
PMID 35399229
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Non-small cell lung cancer (NSCLC) is one of the most aggressive types of cancer worldwide. It has been reported that long non-coding RNAs (lncRNAs) are involved in the pathogenesis of NSCLC. In addition, LINC00152 is known to be upregulated in NSCLC. However, the mechanism underlying the effect of LINC00152 on NSCLC tumorigenesis remains to be elucidated.

Methods: In the present study, cell viability, apoptosis and invasion were investigated by CCK-8, flow cytometry and Transwell assays, respectively. Reverse transcription‑quantitative polymerase chain reaction and Western blotting were performed to determine the mRNA and protein expression levels. In addition, the association between LINC00152, microRNA (miR)-16-5p and BCL2-like 2 (BCL2L2) was evaluated using a dual-luciferase assay.

Results: The results demonstrated that LINC00152-knockdown significantly attenuated the viability of NSCLC cells via promoting cell apoptosis. In addition, the migration and invasion ability of NSCLC cells was also decreased following transfection of cells with LINC00152 siRNA. Furthermore, miR-16-5p inhibitor or BCLCL2-overexpression reversed LINC00152 siRNA-induced NSCLC cell growth inhibition.

Conclusions: The findings of the present study demonstrated that LINC00152-silencing suppressed NSCLC tumorigenesis via regulating the miR-16-5p/BCL2L2 axis. Therefore, linc00152 has the potential as a molecular marker and may be a potential target for the treatment of non-small cell lung cancer.

Citing Articles

Transcriptomics data mining to uncover signature genes in head and neck squamous cell carcinoma: a bioinformatics analysis and RNA-sequencing based validation.

Yu W, He X, Zhang C, Huangfu H Am J Cancer Res. 2023; 13(11):5513-5530.

PMID: 38058845 PMC: 10695818.


circ_SPEF2 Regulates the Balance of Treg Cells by Regulating miR-16-5p/BACH2 in Lymphoma and Participates in the Immune Response.

Zhou J, Xu M, Chen Z, Huang L, Wu Z, Huang Z Tissue Eng Regen Med. 2023; 20(7):1145-1159.

PMID: 37801226 PMC: 10645944. DOI: 10.1007/s13770-023-00585-2.


Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks.

Braga E, Fridman M, Burdennyy A, Loginov V, Dmitriev A, Pronina I Int J Mol Sci. 2023; 24(17).

PMID: 37686426 PMC: 10487663. DOI: 10.3390/ijms241713617.


Screening of four signature genes for clinical testing through bioinformatics and in vitro methods in head and neck squamous cell carcinoma.

Javed M, Bukhari R, Rasool R, Alhomrani M, Alghamdi S, Habeeballah H Am J Cancer Res. 2023; 13(5):1826-1844.

PMID: 37293145 PMC: 10244115.


CYTOR Promotes Proliferation of Lung Cancer Cell by Targeting miR-103a-3p to Upregulate HMGB1.

Xu X, Chen Y, Zhang Y, Cai H, Shen P, Peng J Mol Biotechnol. 2023; 65(9):1528-1538.

PMID: 36697993 DOI: 10.1007/s12033-023-00662-w.


References
1.
Brokatzky D, Kretz O, Hacker G . Apoptosis Functions in Defense against Infection of Mammalian Cells with Environmental Chlamydiae. Infect Immun. 2020; 88(6). PMC: 7240083. DOI: 10.1128/IAI.00851-19. View

2.
Yin K, Cui Y, Qu Y, Zhang J, Zhang H, Lin H . Hydrogen sulfide upregulates miR-16-5p targeting PiK3R1 and RAF1 to inhibit neutrophil extracellular trap formation in chickens. Ecotoxicol Environ Saf. 2020; 194:110412. DOI: 10.1016/j.ecoenv.2020.110412. View

3.
Zhou X, Zhang Z, Liang X . Regulatory Network Analysis to Reveal Important miRNAs and Genes in Non-Small Cell Lung Cancer. Cell J. 2019; 21(4):459-466. PMC: 6722447. DOI: 10.22074/cellj.2020.6281. View

4.
Kaci F, Kiraz Y, Cekdemir D, Baran Y . Synergistic Apoptotic Effects of Bortezomib and Methylstat on Multiple Myeloma Cells. Arch Med Res. 2020; 51(3):187-193. DOI: 10.1016/j.arcmed.2020.01.012. View

5.
Seo D, Kim D, Kim W . Long non-coding RNA linc00152 acting as a promising oncogene in cancer progression. Genomics Inform. 2020; 17(4):e36. PMC: 6944044. DOI: 10.5808/GI.2019.17.4.e36. View